FDA bars critic from review panel of Biogen's controversial Alzheimer's drug - Reuters

Reuters | Nov. 2, 2020, 1:15 p.m. | Original
FDA bars critic from review panel of Biogen's controversial Alzheimer's drug Reuters
Rebound in factory output lifts European stocks after selloff last week - Reuters France sees record number of new COVID-19 cases, hospitalisations spike - Reuters